General Information of the Compound
| Compound ID |
CP0040528
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(4,5-Diphenyl-oxazol-2-yl)-propionic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
3-(4, 5-Diphenyl-2-oxazo
3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid
3-(4,5-Diphenyl-2-oxazolyl)propenoic acid
4, 5-Diphenyl-2-oxazolepropionic acid
4,5-Diphenyl-2-oxazolepropanoic acid
4,5-Diphenyl-2-oxazolepropionic acid
Actirin
Alvo
Apo-Oxaprozin
Apotex brand of oxaprozin
Beta-(4,5-Diphenyloxazol-2-yl)propionic acid
CSC brand of oxaprozin
Danoprox
Daypro
Daypro (TN)
Dayrun
Deflam
Duraprox (TN)
Lyl)propenoic acid
NCI310839
O 9637
Oxaprozin
Oxaprozin (JP15/USAN/INN)
Oxaprozin [USAN:BAN:INN:JAN]
Oxaprozina
Oxaprozina [INN-Spanish]
Oxaprozine
Oxaprozine [INN-French]
Oxaprozinum
Oxaprozinum [INN-Latin]
Pfizer brand of oxaprozin
Rhoxal-oxaprozin
Rhoxalpharma brand of oxaprozin
TRB brand of oxaprozin
Voir
WY 21743
WY-21,743
WY-21743
Xopane
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H15NO3
|
||||||||||||||||||
| Molecular Weight |
293.322
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)
Show/Hide
|
||||||||||||||||||
| InChIKey |
OFPXSFXSNFPTHF-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
21256-18-8
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05334, ATP-binding cassette sub-family C member 4
Protein ID: PT06109, Geminin
Protein ID: PT01930, Retinoic acid receptor RXR-alpha
Protein ID: PT01474, Retinoic acid receptor RXR-beta
Protein ID: PT02769, Retinoic acid receptor RXR-gamma
Clinical Information about the Compound